Logo
STYLAGE XL Lidocaine (2 x 1 ml)

STYLAGE XL Lidocaine (2 x 1 ml)

STYLAGE

Aesthetic / Dermal Filler
  • CE‑marked Class III medical device under Vivacy quality standards for injectable HA fillers. :contentReference[oaicite:28]{index=28}
  • Manufactured under IPN‑Like cross‑linking technology for improved gel stability and longevity. :contentReference[oaicite:29]{index=29}
Facial volume restoration & contouring

Description

STYLAGE XL Lidocaine is a sterile, monophasic, antioxidant cross‑linked hyaluronic acid gel (IPN‑Like technology) with 26 mg/ml HA concentration and 0.3% lidocaine, intended for deep dermis or subcutaneous injection to restore lost facial volume, re‑contour facial structure, and correct deep wrinkles or skin sagging.

Bnefits

  • Restores lost facial volume and structural support (cheeks, chin, jawline, temples, cheeks) :contentReference[oaicite:0]{index=0}
  • Provides volumizing and lifting effect to correct sagging skin and facial hollows :contentReference[oaicite:1]{index=1}
  • Contains 0.3% lidocaine for increased injection comfort and reduced pain during treatment :contentReference[oaicite:2]{index=2}
  • Includes antioxidant mannitol to slow HA degradation and reduce post-injection inflammation and oxidative stress, improving gel longevity :contentReference[oaicite:3]{index=3}
  • Long‑lasting results — typically 12 to 18 months depending on treated area, skin, and patient factors :contentReference[oaicite:4]{index=4}

Indications

  • Facial volume restoration (cheeks, cheekbones, jawline, chin, temples) :contentReference[oaicite:5]{index=5}
  • Correction of facial hollows or fat loss (age‑related or due to lipodystrophy) :contentReference[oaicite:6]{index=6}
  • Reshaping and contouring of facial structure (face oval, chin, jawline) for a more youthful appearance :contentReference[oaicite:7]{index=7}
  • Treatment of deep wrinkles, folds or skin sagging, especially in thick skin or deep‑wrinkle patients :contentReference[oaicite:8]{index=8}
  • Optional: hand rejuvenation or volume restoration on hands or back of hands in case of fat loss/facial lipodystrophy according to some distributor sources :contentReference[oaicite:9]{index=9}

Composition

  • Cross‑linked hyaluronic acid (IPN‑Like) — 26 mg/ml HA gel :contentReference[oaicite:10]{index=10}
  • Mannitol (antioxidant) to protect HA from oxidative degradation and reduce post-injection inflammation :contentReference[oaicite:11]{index=11}
  • Lidocaine hydrochloride 0.3% (local anaesthetic) for injection comfort :contentReference[oaicite:12]{index=12}
  • Phosphate buffer (pH 7.2) and other excipients per manufacturer formulation :contentReference[oaicite:13]{index=13}

Formulation

  • Sterile, biodegradable monophasic cross-linked HA gel using IPN‑Like® Technology with antioxidant and local anaesthetic (lidocaine) additive (Bi‑SOFT formulation) :contentReference[oaicite:14]{index=14}

Packaging

  • 2 × 1 ml pre-filled sterile syringes (glass, latex-free) with single-use needles (commonly 27G½ or 23G depending on distributor) :contentReference[oaicite:15]{index=15}

Usage

  • For use by qualified and trained medical professionals only. :contentReference[oaicite:16]{index=16}
  • Inject into deep dermis or subcutaneous layer depending on area treated, using appropriate injection technique (needle or cannula) to ensure even distribution. :contentReference[oaicite:17]{index=17}
  • Post‑treatment care: avoid extreme heat or cold, excessive sun exposure, strenuous exercise, and avoid massaging treated areas for initial 48–72 h, per distributor guidance. :contentReference[oaicite:18]{index=18}

Contraindications

  • Hypersensitivity to hyaluronic acid, lidocaine or any component of the formulation :contentReference[oaicite:21]{index=21}
  • Active skin infection, inflammation or lesions at injection site :contentReference[oaicite:22]{index=22}
  • Pregnancy or breastfeeding (use not recommended) :contentReference[oaicite:23]{index=23}
  • Use in minors under legal adult age or per local regulatory practice :contentReference[oaicite:24]{index=24}

Adverse Effects

  • Transient injection-site reactions: redness, swelling, bruising, tenderness, itching or firmness. :contentReference[oaicite:25]{index=25}
  • Rare but serious: risk of nodules, granulomas, vascular occlusion, or allergic reactions especially if improperly injected — requires experienced practitioner and emergency protocols (e.g. hyaluronidase) :contentReference[oaicite:26]{index=26}

Storage Conditions

  • Store between 2 °C and 25 °C, protect from freezing, excessive heat and direct sunlight; keep syringes sealed until use. :contentReference[oaicite:27]{index=27}

Duration

12\u201318 months (depending on treated area, skin type, metabolism, and technique) :contentReference[oaicite:19]{index=19}

Onset

Immediate volumizing/contour improvement visible upon injection; optimal aesthetic result after initial swelling subsides (usually within days) :contentReference[oaicite:20]{index=20}

Browse more Aesthetic / Dermal Filler

Top Treatments

Top Cities in the UK